A Belfast-based company has raised £8.8 million in funding as it looks to further develop its incredible biometrics technology.

B-Secur’s Heartkey monitoring tech can identify an individual from their unique heartbeat and could be huge in at-home health monitoring.

It said the funding will enable expansion in the consumer and medical industries in the US.

The money, raised throughout 2021, comes from Wharton Asset Management, Kernel Capital and Co-Fund NI (managed by Clarendon Fund Managers) plus first-time US investment from Denver-based First Capital Ventures.

“Having received FDA clearance for our HeartKey ECG technology earlier this year, we’ve been working to grow our existing base in Belfast with more highly skilled people and to establish a stronger presence in the US,” said B-Secur co-founder and CEO Alan Foreman. 

“This investment is a strong testimony to our cutting-edge ECG technology and B-Secur’s global scalability.”

‘We headed straight to the US to beat our rivals’

Gary Graham, executive MD at First Capital Ventures, said: “At First Capital Ventures we have no doubt that the ground-breaking work B-Secur is doing has the power to be truly transformative.

“We are looking forward to a joint contribution and the benefit of uniquely combining B-Secur’s attributes with ours – both intellectually and economically.”